Clinical Study
Azilsartan as “Add-On” Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis
Table 3
Effect of azilsartan (Azil) on different functional areas of HAQDI score of patients with active RA maintained on methotrexate (MTX).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are expressed as mean ± S.D; n: number of patients; different compared to pretreatment ; posttreatment values with different superscripts (a, b) within each parameter are significantly different . HAQ-DI: health assessment questionnaire disability index; RA: rheumatoid arthritis. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||